138 related articles for article (PubMed ID: 33014019)
21. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Jang BS; Kim IA
Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
[TBL] [Abstract][Full Text] [Related]
22. Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma.
Wu S; Dai X; Xie D
Front Genet; 2019; 10():1252. PubMed ID: 31921296
[TBL] [Abstract][Full Text] [Related]
23. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
24. A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Liu N; Boohaker RJ; Jiang C; Boohaker JR; Xu B
Oncotarget; 2015 Oct; 6(33):34649-57. PubMed ID: 26452218
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma.
Yang B; Shen J; Xu L; Chen Y; Che X; Qu X; Liu Y; Teng Y; Li Z
Front Oncol; 2019; 9():898. PubMed ID: 31620361
[No Abstract] [Full Text] [Related]
26. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Yang J; Xie K; Li C
Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
[TBL] [Abstract][Full Text] [Related]
28. Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma.
Zeng H; Chen L; Huang Y; Luo Y; Ma X
Front Cell Dev Biol; 2020; 8():553099. PubMed ID: 33195188
[TBL] [Abstract][Full Text] [Related]
29. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer.
Noh JK; Woo SR; Yun M; Lee MK; Kong M; Min S; Kim SI; Lee YC; Eun YG; Ko SG
Cancer Genomics Proteomics; 2021; 18(5):675-684. PubMed ID: 34479919
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
Ma J; Li R; Wang J
Mol Med Rep; 2019 Jul; 20(1):622-632. PubMed ID: 31180552
[TBL] [Abstract][Full Text] [Related]
31. A multi-omics signature to predict the prognosis of invasive ductal carcinoma of the breast.
Lin Z; He Y; Qiu C; Yu Q; Huang H; Yiwen Zhang ; Li W; Qiu T; Xiaoping Li
Comput Biol Med; 2022 Dec; 151(Pt A):106291. PubMed ID: 36395590
[TBL] [Abstract][Full Text] [Related]
32. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
33. A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma.
Xing L; Guo M; Zhang X; Zhang X; Liu F
J Cancer Res Clin Oncol; 2020 Mar; 146(3):621-630. PubMed ID: 32067104
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Si S; Li X; Sun W; Cui L
J Cancer; 2020; 11(15):4571-4580. PubMed ID: 32489474
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity.
Feng B; Wang K; Herpel E; Plath M; Weichert W; Freier K; Zaoui K; Hess J
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680330
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Li J; Li Y; Wu X; Li Y
Oncol Lett; 2019 Jun; 17(6):5642-5652. PubMed ID: 31186787
[TBL] [Abstract][Full Text] [Related]
37. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Pan Y; Song Y; Cheng L; Xu H; Liu J
J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
39. ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.
Göttgens EL; van den Heuvel CN; de Jong MC; Kaanders JH; Leenders WP; Ansems M; Bussink J; Span PN
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817870
[TBL] [Abstract][Full Text] [Related]
40. An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma.
Liang Y; Feng G; Zhong S; Gao X; Tong Y; Cui W; Huang G; Zhang Z; Zhou X
Med Sci Monit; 2019 Jun; 25():4485-4494. PubMed ID: 31203306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
